US Patent 7390925 Oxime-containing acyl guanidines as beta-secretase inhibitors
Patent 7390925 was granted and assigned to Bristol-Myers Squibb on June, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 14 Sep, 2023
Golden AI
Edits made to:
Article (+104 characters)
Article
Patent abstract
There is provided a series of substituted oxime-containing acyl guanidines of Formula (I)
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07390925 Oxime-containing acyl guanidines as beta-secretase inhibitors US Patent 7390925 Oxime-containing acyl guanidines as beta-secretase inhibitors
Infobox
Patent Number
0739092500
Patent Number
739092500
Edits on 1 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073909250
Date of Patent
June 24, 2008
0Patent Application Number
116930260
Date Filed
March 29, 2007
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073909250
Date of Patent
June 24, 2008
0Patent Application Number
116930260
Date Filed
March 29, 2007
0Official Website
Patent Primary Examiner
Edits on 9 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 30 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07390925 Oxime-containing acyl guanidines as beta-secretase inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07390925
Date of patent
June 24, 2008
Patent application number
11693026
Date Filed
March 29, 2007
Patent primary examiner
Find more entities like US Patent 7390925 Oxime-containing acyl guanidines as beta-secretase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
